Literature DB >> 21551275

Catalase overexpression in aortic smooth muscle prevents pathological mechanical changes underlying abdominal aortic aneurysm formation.

Kathryn Maiellaro-Rafferty1, Daiana Weiss, Giji Joseph, William Wan, Rudolph L Gleason, W Robert Taylor.   

Abstract

The causality of the associations between cellular and mechanical mechanisms of abdominal aortic aneurysm (AAA) formation has not been completely defined. Because reactive oxygen species are established mediators of AAA growth and remodeling, our objective was to investigate oxidative stress-induced alterations in aortic biomechanics and microstructure during subclinical AAA development. We investigated the mechanisms of AAA in an angiotensin II (ANG II) infusion model of AAA in apolipoprotein E-deficient (apoE(-/-)) mice that overexpress catalase in vascular smooth muscle cells (apoE(-/-)xTg(SMC-Cat)). At baseline, aortas from apoE(-/-)xTg(SMC-Cat) exhibited increased stiffness and the microstructure was characterized by 50% more collagen content and less elastin fragmentation. ANG II treatment for 7 days in apoE(-/-) mice altered the transmural distribution of suprarenal aortic circumferential strain (quantified by opening angle, which increased from 130 ± 1° at baseline to 198 ± 8° after 7 days of ANG II treatment) without obvious changes in the aortic microstructure. No differences in aortic mechanical behavior or suprarenal opening angle were observed in apoE(-/-)xTg(SMC-Cat) after 7 days of ANG II treatment. These data suggest that at the earliest stages of AAA development H(2)O(2) is functionally important and is involved in the control of local variations in remodeling across the vessel wall. They further suggest that reduced elastin integrity at baseline may predispose the abdominal aorta to aneurysmal mechanical remodeling.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21551275      PMCID: PMC3154675          DOI: 10.1152/ajpheart.00040.2011

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  43 in total

1.  Transmural strain distribution in the blood vessel wall.

Authors:  Xiaomei Guo; Xiao Lu; Ghassan S Kassab
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-02       Impact factor: 4.733

2.  Experimental investigation of the distribution of residual strains in the artery wall.

Authors:  S E Greenwald; J E Moore; A Rachev; T P Kane; J J Meister
Journal:  J Biomech Eng       Date:  1997-11       Impact factor: 2.097

Review 3.  Role of oxidative stress in the pathogenesis of abdominal aortic aneurysms.

Authors:  Michael L McCormick; Dan Gavrila; Neal L Weintraub
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-01-11       Impact factor: 8.311

4.  Vascular hypertrophy in angiotensin II-induced hypertension is mediated by vascular smooth muscle cell-derived H2O2.

Authors:  Yong Zhang; Kathy K Griendling; Anna Dikalova; Gary K Owens; W Robert Taylor
Journal:  Hypertension       Date:  2005-09-19       Impact factor: 10.190

5.  MMP-12 has a role in abdominal aortic aneurysms in mice.

Authors:  G Matthew Longo; Steven J Buda; Nicola Fiotta; Wanfen Xiong; Timothy Griener; Steven Shapiro; B Timothy Baxter
Journal:  Surgery       Date:  2005-04       Impact factor: 3.982

6.  Vitamin E inhibits abdominal aortic aneurysm formation in angiotensin II-infused apolipoprotein E-deficient mice.

Authors:  Dan Gavrila; Wei Gen Li; Michael L McCormick; Manesh Thomas; Alan Daugherty; Lisa A Cassis; Francis J Miller; Larry W Oberley; Kevin C Dellsperger; Neal L Weintraub
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-06-02       Impact factor: 8.311

7.  Proteoglycan gene expression is decreased in abdominal aortic aneurysms.

Authors:  N A Tamarina; M A Grassi; D A Johnson; W H Pearce
Journal:  J Surg Res       Date:  1998-01       Impact factor: 2.192

8.  Deletion of p47phox attenuates angiotensin II-induced abdominal aortic aneurysm formation in apolipoprotein E-deficient mice.

Authors:  Manesh Thomas; Dan Gavrila; Michael L McCormick; Francis J Miller; Alan Daugherty; Lisa A Cassis; Kevin C Dellsperger; Neal L Weintraub
Journal:  Circulation       Date:  2006-07-24       Impact factor: 29.690

9.  Tamoxifen up-regulates catalase production, inhibits vessel wall neutrophil infiltration, and attenuates development of experimental abdominal aortic aneurysms.

Authors:  Vladimir Grigoryants; Kevin K Hannawa; Charles G Pearce; Indranil Sinha; Karen J Roelofs; Gorav Ailawadi; Kristopher B Deatrick; Derek T Woodrum; Brenda S Cho; Peter K Henke; James C Stanley; Matthew J Eagleton; Gilbert R Upchurch
Journal:  J Vasc Surg       Date:  2005-01       Impact factor: 4.268

10.  Elastin degradation and calcification in an abdominal aorta injury model: role of matrix metalloproteinases.

Authors:  Dina M Basalyga; Dan T Simionescu; Wanfen Xiong; B Timothy Baxter; Barry C Starcher; Narendra R Vyavahare
Journal:  Circulation       Date:  2004-11-15       Impact factor: 29.690

View more
  22 in total

1.  Smooth muscle cells isolated from thoracic aortic aneurysms exhibit increased genomic damage, but similar tendency for apoptosis.

Authors:  Ceyda Acilan; Muge Serhatli; Omer Kacar; Zelal Adiguzel; Altug Tuncer; Mutlu Hayran; Kemal Baysal
Journal:  DNA Cell Biol       Date:  2012-08-07       Impact factor: 3.311

2.  Relationship between Serum Gamma-glutamyl Transferase Levels with Ascending Aortic Dilatation.

Authors:  Ahmet Kaya; Yasemin Kaya; Zeki Yuksel Gunaydin; Ozgur Enginyurt; Yavuz Kursat Polat; Selim Topcu; Murat Saritemur
Journal:  Eurasian J Med       Date:  2014-06

3.  Regulatory T cells in human and angiotensin II-induced mouse abdominal aortic aneurysms.

Authors:  Yi Zhou; Wenxue Wu; Jes S Lindholt; Galina K Sukhova; Peter Libby; Xueqing Yu; Guo-Ping Shi
Journal:  Cardiovasc Res       Date:  2015-03-30       Impact factor: 10.787

4.  Transmural variation in elastin fiber orientation distribution in the arterial wall.

Authors:  Xunjie Yu; Yunjie Wang; Yanhang Zhang
Journal:  J Mech Behav Biomed Mater       Date:  2017-08-05

5.  Overexpression of catalase in vascular smooth muscle cells prevents the formation of abdominal aortic aneurysms.

Authors:  Ioannis Parastatidis; Daiana Weiss; Giji Joseph; W Robert Taylor
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-08-15       Impact factor: 8.311

Review 6.  Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology.

Authors:  Steven J Forrester; George W Booz; Curt D Sigmund; Thomas M Coffman; Tatsuo Kawai; Victor Rizzo; Rosario Scalia; Satoru Eguchi
Journal:  Physiol Rev       Date:  2018-07-01       Impact factor: 37.312

Review 7.  Paradoxical Roles of Antioxidant Enzymes: Basic Mechanisms and Health Implications.

Authors:  Xin Gen Lei; Jian-Hong Zhu; Wen-Hsing Cheng; Yongping Bao; Ye-Shih Ho; Amit R Reddi; Arne Holmgren; Elias S J Arnér
Journal:  Physiol Rev       Date:  2016-01       Impact factor: 37.312

8.  Polymerase delta interacting protein 2 sustains vascular structure and function.

Authors:  Roy L Sutliff; Lula L Hilenski; Angélica M Amanso; Ioannis Parastatidis; Anna E Dikalova; Laura Hansen; Srinivasa Raju Datla; James S Long; Alexander M El-Ali; Giji Joseph; Rudolph L Gleason; W Robert Taylor; C Michael Hart; Kathy K Griendling; Bernard Lassègue
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-07-03       Impact factor: 8.311

9.  Caveolin 1 is critical for abdominal aortic aneurysm formation induced by angiotensin II and inhibition of lysyl oxidase.

Authors:  Takehiko Takayanagi; Kevin J Crawford; Tomonori Kobayashi; Takashi Obama; Toshiyuki Tsuji; Katherine J Elliott; Tomoki Hashimoto; Victor Rizzo; Satoru Eguchi
Journal:  Clin Sci (Lond)       Date:  2014-06       Impact factor: 6.124

10.  Oxidative stress modulates vascular smooth muscle cell phenotype via CTGF in thoracic aortic aneurysm.

Authors:  Emanuela Branchetti; Paolo Poggio; Rachana Sainger; Eric Shang; Juan B Grau; Benjamin M Jackson; Eric K Lai; Michael S Parmacek; Robert C Gorman; Joseph H Gorman; Joseph E Bavaria; Giovanni Ferrari
Journal:  Cardiovasc Res       Date:  2013-08-28       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.